UK Turmeric Supplement Ads Outed For Using Claims 'On Hold' At EFSA
This article was originally published in The Rose Sheet
Executive Summary
In separate rulings, ASA upholds complains that Healthspan and Cambridge Nutraceuticals made unapproved health claims for turmeric, as the firms did not provide sufficient supporting evidence and cannot rely on similar “on hold” claims on the ingredient under review by EFSA.
You may also be interested in...
UK Turmeric Shot Marketer Served A Regulatory Lesson For Unauthorized Pain Relief Claims
Firm apologized and removed a Facebook post that promised to rid users of stubborn aches and pains after Advertising Standards Authority determined claims were unauthorized.
Formula Claims Draft Guidance: Health And Wellness Industry News Roundup
FTC considers Vemma settlement; UK firm's green tea claim fails; Axxess has new CEO; NeutraSci reaches Austria, Germany; and more news in brief.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.